Researchers at Cincinnati Children's Hospital Medical Center may have discovered a way to use gene therapy to cure sickle-cell anemia after a decade of research work.
Using lab animals and human tissue samples, scientists have been able to develop the cutting-edge treatment for a disease that affects 70,000 to 100,000 people in the United States. The hope is to receive federal approval to move forward with human testing next year.
Read full article
here.
Enjoy this story?
Sign up for free solutions-based reporting in your inbox each week.